LSPW
MRNA icon

Lake Street Private Wealth’s Moderna MRNA Stock Holding History

Lake Street Private Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,241
Closed -$239K – 331
2024
Q1 		$239K Buy
+2,241
New +$226K 0.03% 286
2023
Q4 		– Sell
-2,146
Closed -$215K – 313
2023
Q3 		$215K Sell
2,146
-282
-12% -$31.5K 0.04% 258
2023
Q2 		$295K Buy
2,428
+300
+14% +$40K 0.05% 230
2023
Q1 		$327K Buy
2,128
+135
+7% +$22.3K 0.06% 219
2022
Q4 		$358K Buy
1,993
+44
+2% +$7.19K 0.07% 207
2022
Q3 		$230K Buy
1,949
+201
+11% +$30.5K 0.05% 243
2022
Q2 		$250K Buy
1,748
+84
+5% +$12K 0.05% 253
2022
Q1 		$287K Sell
1,664
-135
-8% -$22.7K 0.05% 256
2021
Q4 		$457K Buy
1,799
+1,096
+156% +$320K 0.08% 208
2021
Q3 		$271K Buy
+703
New +$259K 0.07% 191

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lake Street Private Wealth's MRNA Position: Q2 2024 in Review

Lake Street Private Wealth sold out of Moderna (MRNA) in Q2 2024, closing a stake of 2,241 shares — an estimated $239K sold.

Lake Street Private Wealth first reported a position in MRNA in Q3 2021 and held it in 10 quarters. The position peaked at $457K in Q4 2021. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Lake Street Private Wealth reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Lake Street Private Wealth sold 2,241 Moderna shares in Q2 2024, an estimated $239K.
  • Lake Street Private Wealth first reported a position in Moderna in Q3 2021 and held it in 10 quarters.
  • Lake Street Private Wealth's Moderna position peaked at $457K in Q4 2021.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Lake Street Private Wealth's 13F filing for Q2 2024, filed 12 Jul 2024.